Physician profile
Jamie Ball
NPI 1578813655
$1,198.81
in general payments reported to CMS, 2019-2025
23 companies · $57.87 in 2025
The $57.87 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2022: $564 · 2023: $220 · 2024: $84.31 · 2025: $57.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.74 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $327.29 | 2021-2023 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $144.96 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $89.45 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.21 | 2022-2024 | Ofev |
| Abbvie INC. | $58.59 | 2021 | |
| Pulmonx Corporation | $53.29 | 2024 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Actelion Pharmaceuticals US, INC. | $47.36 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $44.24 | 2022 | |
| Eisai INC. | $43.63 | 2021 | |
| Boston Scientific Corporation | $40.49 | 2025 | Lithovue, Rezum Generator |
| Genzyme Corporation | $36.92 | 2022 | |
| Harmony Biosciences LLC | $34.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.58 | 2022 | |
| Bausch Health US, LLC | $22.71 | 2021 | |
| United Therapeutics Corporation | $19.05 | 2023 | Tyvaso |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $18.42 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.06 | 2021 | |
| Insmed, INC. | $17.38 | 2025 | |
| Electromed, INC. | $17.08 | 2022 | |
| Allergan, INC. | $15.72 | 2021 | |
| Novo Nordisk INC | $14.77 | 2021 | |
| Amgen INC. | $14.16 | 2023 | Tezspire |
| Lilly USA, LLC | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.